Loading...
Dynamic contrast-enhanced MRI in patients with muscle-invasive transitional cell carcinoma of the bladder can distinguish between residual tumour and post-chemotherapy effect.
Donaldson, Stephanie B Bonington, Suzanne C Kershaw, Lucy E Cowan, Richard A Lyons, Jeanette Elliott, Tony Carrington, Bernadette M
Donaldson, Stephanie B
Bonington, Suzanne C
Kershaw, Lucy E
Cowan, Richard A
Lyons, Jeanette
Elliott, Tony
Carrington, Bernadette M
Citations
Altmetric:
Abstract
Treatment of muscle-invasive bladder cancer with chemotherapy results in haemorrhagic inflammation, mimicking residual tumour on conventional MR images and making interpretation difficult. The aim of this study was to use dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to estimate descriptive and tracer kinetic parameters post-neoadjuvant chemotherapy and to investigate whether parameters differed in areas of residual tumour and chemotherapy-induced haemorrhagic inflammation (treatment effect, Tr-Eff).
Description
Date
2013-08-15
Publisher
Collections
Keywords
Type
Article
Citation
Dynamic contrast-enhanced MRI in patients with muscle-invasive transitional cell carcinoma of the bladder can distinguish between residual tumour and post-chemotherapy effect. 2013: Eur J Radiol